Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982487023> ?p ?o ?g. }
- W1982487023 endingPage "631" @default.
- W1982487023 startingPage "622" @default.
- W1982487023 abstract "Subchronic administration of the N-methyl-d-aspartate receptor antagonist, phencyclidine (PCP), in rodents has been shown to produce impairment in novel object recognition (NOR), a model of visual learning and memory. We tested the hypothesis that the selective 5-HT(2A) inverse agonists, pimavanserin and (R)-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl]-4-piperidinemethanol (M100907), would potentiate subeffective doses of atypical antipsychotic drugs (APDs) to reverse the NOR deficits. Female rats received vehicle or PCP (2 mg/kg b.i.d.) for 7 days, followed by a 7-day washout. Pimavanserin (3 mg/kg) or M100907 (1 mg/kg) alone, or four atypicial APDs, risperidone (0.05-0.1 mg/kg), melperone (1-3 mg/kg), olanzapine (1-2 mg/kg), or N-desmethylclozapine (1-2 mg/kg), and the typical APD, haloperidol (0.05-0.1 mg/kg), were administered alone, or in combination with pimavanserin or M100907, before NOR testing. The exploration times of objects during 3-min acquisition and retention trials, separated by a 1-min interval, were compared by analysis of variance. Vehicle-, but not PCP-treated, animals, explored the novel object significantly more than the familiar in the retention trial (p < 0.05-0.01). Pretreatment with the higher doses of the atypical APDs, but not pimavanserin, M100907, or haloperidol alone, reversed the effects of PCP. The effect of risperidone was blocked by haloperidol pretreatment. Coadministration of pimavanserin or M100907, with ineffective doses of the atypical APDs, but not haloperidol, also reversed the PCP-induced deficit in NOR. These results support the importance of 5-hydroxytryptamine(2A) receptor blockade relative to D(2) receptor blockade in the ability of atypicals to ameliorate the effect of subchronic PCP, a putative measure of cognitive dysfunction in schizophrenia." @default.
- W1982487023 created "2016-06-24" @default.
- W1982487023 creator A5035731595 @default.
- W1982487023 creator A5041400343 @default.
- W1982487023 creator A5049098570 @default.
- W1982487023 creator A5056186383 @default.
- W1982487023 creator A5060651833 @default.
- W1982487023 creator A5060728653 @default.
- W1982487023 creator A5076176832 @default.
- W1982487023 date "2009-10-28" @default.
- W1982487023 modified "2023-09-27" @default.
- W1982487023 title "Attenuation of Phencyclidine-Induced Object Recognition Deficits by the Combination of Atypical Antipsychotic Drugs and Pimavanserin (ACP 103), a 5-Hydroxytryptamine<sub>2A</sub> Receptor Inverse Agonist" @default.
- W1982487023 cites W1497084816 @default.
- W1982487023 cites W1591588997 @default.
- W1982487023 cites W162223338 @default.
- W1982487023 cites W1964176367 @default.
- W1982487023 cites W1971184880 @default.
- W1982487023 cites W1972119507 @default.
- W1982487023 cites W1979700184 @default.
- W1982487023 cites W1981445835 @default.
- W1982487023 cites W1989397869 @default.
- W1982487023 cites W2006369614 @default.
- W1982487023 cites W2008639041 @default.
- W1982487023 cites W2014776578 @default.
- W1982487023 cites W2016773485 @default.
- W1982487023 cites W2016971515 @default.
- W1982487023 cites W2028287654 @default.
- W1982487023 cites W2030439164 @default.
- W1982487023 cites W2031702230 @default.
- W1982487023 cites W2034967655 @default.
- W1982487023 cites W2035601252 @default.
- W1982487023 cites W2054002536 @default.
- W1982487023 cites W2058889376 @default.
- W1982487023 cites W2062009247 @default.
- W1982487023 cites W2066287357 @default.
- W1982487023 cites W2068026066 @default.
- W1982487023 cites W2072180646 @default.
- W1982487023 cites W2082531935 @default.
- W1982487023 cites W2084760609 @default.
- W1982487023 cites W2106352416 @default.
- W1982487023 cites W2106676000 @default.
- W1982487023 cites W2112739763 @default.
- W1982487023 cites W2140390949 @default.
- W1982487023 cites W2148786261 @default.
- W1982487023 cites W2161441546 @default.
- W1982487023 cites W2168545629 @default.
- W1982487023 cites W2170792659 @default.
- W1982487023 doi "https://doi.org/10.1124/jpet.109.156349" @default.
- W1982487023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19864614" @default.
- W1982487023 hasPublicationYear "2009" @default.
- W1982487023 type Work @default.
- W1982487023 sameAs 1982487023 @default.
- W1982487023 citedByCount "83" @default.
- W1982487023 countsByYear W19824870232012 @default.
- W1982487023 countsByYear W19824870232013 @default.
- W1982487023 countsByYear W19824870232014 @default.
- W1982487023 countsByYear W19824870232015 @default.
- W1982487023 countsByYear W19824870232016 @default.
- W1982487023 countsByYear W19824870232017 @default.
- W1982487023 countsByYear W19824870232018 @default.
- W1982487023 countsByYear W19824870232019 @default.
- W1982487023 countsByYear W19824870232020 @default.
- W1982487023 countsByYear W19824870232021 @default.
- W1982487023 countsByYear W19824870232022 @default.
- W1982487023 countsByYear W19824870232023 @default.
- W1982487023 crossrefType "journal-article" @default.
- W1982487023 hasAuthorship W1982487023A5035731595 @default.
- W1982487023 hasAuthorship W1982487023A5041400343 @default.
- W1982487023 hasAuthorship W1982487023A5049098570 @default.
- W1982487023 hasAuthorship W1982487023A5056186383 @default.
- W1982487023 hasAuthorship W1982487023A5060651833 @default.
- W1982487023 hasAuthorship W1982487023A5060728653 @default.
- W1982487023 hasAuthorship W1982487023A5076176832 @default.
- W1982487023 hasConcept C118552586 @default.
- W1982487023 hasConcept C126322002 @default.
- W1982487023 hasConcept C15744967 @default.
- W1982487023 hasConcept C170493617 @default.
- W1982487023 hasConcept C185592680 @default.
- W1982487023 hasConcept C2775870346 @default.
- W1982487023 hasConcept C2776412080 @default.
- W1982487023 hasConcept C2776885963 @default.
- W1982487023 hasConcept C2776921671 @default.
- W1982487023 hasConcept C2778851735 @default.
- W1982487023 hasConcept C2778938600 @default.
- W1982487023 hasConcept C2780057945 @default.
- W1982487023 hasConcept C2780494398 @default.
- W1982487023 hasConcept C2780948584 @default.
- W1982487023 hasConcept C513476851 @default.
- W1982487023 hasConcept C67018056 @default.
- W1982487023 hasConcept C71924100 @default.
- W1982487023 hasConcept C98274493 @default.
- W1982487023 hasConceptScore W1982487023C118552586 @default.
- W1982487023 hasConceptScore W1982487023C126322002 @default.
- W1982487023 hasConceptScore W1982487023C15744967 @default.
- W1982487023 hasConceptScore W1982487023C170493617 @default.
- W1982487023 hasConceptScore W1982487023C185592680 @default.
- W1982487023 hasConceptScore W1982487023C2775870346 @default.
- W1982487023 hasConceptScore W1982487023C2776412080 @default.